Clinical Trial Update: SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for SARC023 evaluating ganetespib and sirolimus in malignant peripheral nerve sheath tumors (MPNST) across Phase 1 and Phase 2, with compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Peripheral Nerve Sheath Tumors
• Sarcoma

Drugs mentioned

• Ganetespib (ganetespib)
• Sirolimus (Sirolimus)

Snippet

Sponsor: Sarcoma Alliance for Research through Collaboration | Conditions: Malignant Peripheral Nerve Sheath Tumors (MPNST), Sarcoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-05-02